* Through this article, 48 people including Han*hee who simply applied for free
Bottom-level purchase of Ildong Pharmaceutical (249420) cumulative 117% surge profit! We have definitely secured it for you, congratulations!
Follow-up to Ildong Pharmaceutical! A soaring stock that will quickly rise from the bottom!! Buy at the low point and hit the jackpot!!
‘o o o’ Omicron oral treatment approved for Phase 2 clinical trial! + Global clinical trials underway simultaneously!
Perfect ‘o o o’ treatment with no side effects! Explosive inquiries from global major pharmaceutical companies
Global clinical trial agency One PICK!! Completed development at unprecedented speed! Export imminent upon result announcement!
Achieved performance exceeding 15 times last year’s sales due to simultaneous development of the world’s first new drug dominating the 300 trillion won global market and surging demand!
You must buy immediately to get in. VI (Volatility Interruption) will be triggered making entry difficult.
World’s first development! Patent already filed! Flood of inquiries from global major corporations!
Neutralizing antibodies reduced 25 times! Over 10 billion times, domestic companies accelerating volume securing!!
Foreign and institutional investors are already accumulating nearly half of the circulating volume!
**Actual member reviews**
“I applied for the free trial and consistently followed for 3 days, and it was really amazing to see limit-up profits every day. When I was doing it alone, hitting limit-ups was so difficult, but tasting it daily made me unable to stop, so I immediately paid the membership fee and am receiving VIP service. Compared to the low membership fee, they make me earn more every day, so I am just grateful. It’s already been 5 months since I properly started, and I have saved 62 million won. Thank you very much.” (VIP office worker Park O-hyun, 37 years old member)
“This stock” that can definitely generate profits, apply for the free trial now and check it out!
We are waiting for your choice.
[Recent limit-up hits]
22.03.28 Adbiotech (179530) Limit-up hit!
22.03.22 Hyundai Feed (016790) 4th Limit-up hit!
22.03.18 Auto& (353590) Limit-up hit!
22.03.11 Hanshin Machinery (011700) Limit-up hit!
22.03.07 Hyosung O&B (097870) Limit-up hit!
22.03.02 Kainos Med (284620) Limit-up hit!
22.02.21 Dijens (113810) Limit-up hit!
22.02.09 GSE (041920) Limit-up hit!
22.02.03 Ildong Pharmaceutical (053950) 2nd Limit-up hit!
22.01.26 Daewon Cable (006340) Limit-up hit!
22.01.21 Auto& (353590) 2nd Limit-up hit!
22.01.18 Korea Petroleum (004090) Limit-up hit!
22.01.12 ABL Bio (298380) Limit-up hit!
[Today’s stocks of interest]
Isu Abxis, Mirae Industry, Harim, U& I, Boxel Bio
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

